Expect near-term downward pressure as the market absorbs the massive overhang. Watch for any immediate ATM sales or registered secondary offerings; further weakness likely until Karyopharm clarifies its financing plan or shows a path to profitability.
KPTI drugs
KPTI drug pipeline →How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · May 15 $7.67entry
- T+1 · 6mo ago −6.91%α −6.85% · $7.14
- T+5 · 6mo ago +6.39%α +5.43% · $8.16
- T+20 · 5mo ago +25.68%α +23.57% · $9.64
- T+60 · due 3mo ago Pending
Price Chart
How similar events traded
Executive Summary
Two shelf registrations effective: a $400M universal shelf (including $100M ATM) and an 8.8M-share resale shelf. This enables immediate equity dilution at a company with a $201M market cap and going-concern doubts, dramatically increasing supply risk.
Key Facts
- Both S-3 shelves (Nos. 333-295533 and 333-295535) declared effective May 14, 2026.
- $400M universal shelf includes $100M ATM; potential dilution ~200% of current market cap.
- 8.8M-share resale shelf for RA Capital (no proceeds to company) also effective.
- Auditor has expressed substantial doubt about Karyopharm's ability to continue as a going concern.
- No financial proceeds from the resale shelf; proceeds from universal shelf would be used for general corporate purposes.
Financial Impact
Potential dilution exceeding 200% of $201M market cap via the $400M universal shelf; additional 8.8M shares from resale shelf (about 4.4% of current float).
Risk Factors
- Immediate dilutive share sales under the ATM or universal shelf.
- Continued going concern uncertainty limiting institutional demand.
- Failure to secure non-dilutive financing alternatives.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (KPTI), Batch item 1 | 9999999995-26-001656 |
| Document: 9999999995-26-001656-index.html | 9999999995-26-001655 |
| Document: 9999999995-26-001656.txt | 9999999995-26-001656 |
| EFFECT Filing (KPTI), Batch item 4 | 9999999995-26-001655 |
| Document: 9999999995-26-001655-index.html | 9999999995-26-001656 |
| Document: 9999999995-26-001655.txt | 9999999995-26-001656 |
Track record
30 reports on KPTI
5 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +97.24% at T+60 after the Aug 13, 2026 report. 12 of 13 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 3/10 Entry $0.0102 Now $0.0290 +184.31% settles Feb 12
- Nov 13, 20263d ago NT 10-Q Bearish 7/10 Entry $0.0102 Now $0.0290 −184.31% settles Feb 12
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $0.0295 Now $0.0290 −1.69% settles Feb 10
- Nov 9, 20267d ago SC 13G/A Neutral 2/10 Entry $0.0400 Now $0.0290 −27.50% settles Feb 5
- Nov 5, 202611d ago 8-K Bearish 8/10 Entry $0.0601 Now $0.0290 +51.75% settles Feb 3
- Nov 2, 202614d ago 8-K Bearish 10/10 Entry $0.0883 Now $0.0290 +67.16% settles Feb 1
- Nov 2, 202614d ago 8-K Bearish 7/10 Entry $0.1120 Now $0.0290 +74.11% settles Jan 29
- Oct 28, 202619d ago SC 13G/A Bearish 5/10 Entry $0.8798 Now $0.0290 +96.70% settles Jan 27
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $0.5175 Now $0.0290 +94.40% settles Jan 21
- Oct 14, 20264w ago 8-K Neutral 3/10 Entry $0.3150 Now $0.0290 −90.79% settles Jan 11
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers